We are live on ! Find out more
T. Rowe Price Associates

T. Rowe Price Associates Portfolio holdings

AUM $865B
1-Year Est. Return 30.76%
 

T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.

This Fund
S&P 500
This Quarter Est. Return
-5.66%
1 Year Est. Return
+30.76%
3 Year Est. Return
+117.39%
5 Year Est. Return
+143.85%
10 Year Est. Return
+1,089.89%
AUM
$449B
AUM Growth
-$36.8B
Cap. Flow
-$692M
Cap. Flow %
-0.15%
Top 10 Hldgs %
15.79%
Holding
2,618
New
86
Increased
1,108
Reduced
800
Closed
108

Top Sells

Rank Stock Value
1
BIDU icon
Baidu
BIDU
+$1.76B
2
BIIB icon
Biogen
BIIB
+$1.47B
3
PCP
PRECISION CASTPARTS CORP
PCP
+$1.26B
4
MCK icon
McKesson
MCK
+$1.2B
5
SHW icon
Sherwin-Williams
SHW
+$1.12B

Sector Composition

Rank Sector Weight
1 Healthcare 21.75%
2 Consumer Discretionary 14.84%
3 Financials 13.9%
4 Technology 11.11%
5 Industrials 9.92%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DFT
1751
DELISTED
DuPont Fabros Technology Inc.
DFT
$839K ﹤0.01%
32,400
+800
+3% +$22.7K
UMPQ
1752
DELISTED
Umpqua Holdings Corp
UMPQ
$836K ﹤0.01%
51,265
EFII
1753
DELISTED
Electronics for Imaging
EFII
$835K ﹤0.01%
19,300
TCRT icon
1754
Alaunos Therapeutics
TCRT
$4.86M
$833K ﹤0.01%
617
+72
+13% +$119K
GBX icon
1755
The Greenbrier Companies
GBX
$1.42B
$832K ﹤0.01%
25,900
CNW
1756
DELISTED
CON-WAY INC.
CNW
$830K ﹤0.01%
17,500
+2,400
+16% +$94.1K
MZTI
1757
The Marzetti Company
MZTI
$3.22B
$829K ﹤0.01%
8,500
-1,200
-12% -$114K
CACI icon
1758
CACI
CACI
$14.8B
$821K ﹤0.01%
11,100
+1,300
+13% +$104K
EME icon
1759
Emcor
EME
$36.7B
$821K ﹤0.01%
18,560
TIME
1760
DELISTED
Time Inc.
TIME
$820K ﹤0.01%
43,039
-91
-0.2% -$1.93K
TRMK icon
1761
Trustmark
TRMK
$2.8B
$814K ﹤0.01%
35,149
ASB icon
1762
Associated Banc-Corp
ASB
$6.07B
$813K ﹤0.01%
45,242
ITGR icon
1763
Integer Holdings
ITGR
$4.25B
$810K ﹤0.01%
15,742
EQC
1764
DELISTED
Equity Commonwealth
EQC
$808K ﹤0.01%
29,650
MLKN icon
1765
MillerKnoll
MLKN
$1.62B
$800K ﹤0.01%
27,750
MCY icon
1766
Mercury Insurance
MCY
$5.81B
$798K ﹤0.01%
15,793
-1,400
-8% -$75K
WEN icon
1767
Wendy's
WEN
$1.65B
$798K ﹤0.01%
92,215
AHL
1768
DELISTED
ASPEN Insurance Holding Limited
AHL
$795K ﹤0.01%
17,100
+1,500
+10% +$71.3K
GLOG
1769
DELISTED
GASLOG LTD
GLOG
$789K ﹤0.01%
82,000
-350,400
-81% -$5.05M
PEI
1770
DELISTED
Pennsylvania Real Estate Investment Trust
PEI
$788K ﹤0.01%
2,651
+694
+35% +$218K
VSAT icon
1771
Viasat
VSAT
$11.4B
$784K ﹤0.01%
12,200
SJI
1772
DELISTED
South Jersey Industries, Inc.
SJI
$784K ﹤0.01%
31,040
RGLS
1773
DELISTED
Regulus Therapeutics
RGLS
$783K ﹤0.01%
998
+15
+2% +$15.4K
DLX icon
1774
Deluxe
DLX
$1.11B
$782K ﹤0.01%
14,028
DAR icon
1775
Darling Ingredients
DAR
$10.4B
$777K ﹤0.01%
69,100
+5,900
+9% +$75.4K

Similar funds

T. Rowe Price Associates's Q3 2015 Portfolio in Review

As of Q3 2015, T. Rowe Price Associates held 2,618 positions worth $449B, down 7.6% from $486B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

T. Rowe Price Associates's Q3 2015 filing shows 86 new, 1,108 increased, 800 reduced and 108 closed positions. Its largest new stake was BAXALTA INC COM STK (DE): 29,330,491 shares worth $924M. The largest sale was Baidu, an estimated $1.76B.

By sector, the portfolio is most concentrated in Healthcare at 22% of assets, down from 23% a quarter earlier, followed by Consumer Discretionary and Financials.

  • T. Rowe Price Associates's largest Q3 2015 buy was BAXALTA INC COM STK (DE): 29,330,491 shares worth $924M.
  • T. Rowe Price Associates added most to Microsoft in Q3 2015, an estimated $1.57B increase.
  • T. Rowe Price Associates's biggest Q3 2015 reduction was Baidu, cutting an estimated $1.76B.
  • T. Rowe Price Associates fully exited HOSPIRA INC in Q3 2015, selling an estimated $988M.
  • T. Rowe Price Associates's ten largest holdings make up 16% of its $449B portfolio in Q3 2015.
  • T. Rowe Price Associates opened 86 new positions and closed 108 in Q3 2015.
  • T. Rowe Price Associates's portfolio value fell 7.6% quarter-over-quarter to $449B.

Based on T. Rowe Price Associates's 13F filing for Q3 2015, filed 13 Nov 2015.